Methamphetamine administration causes overexpression of nNOS in the mouse striatum

Brain Research

Volumn 851, Issue 1-2, 1999, Pages 254-257

  Deng, Xiaolin ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Methamphetamine; Neurotoxicity; Nitric oxide synthase

Indexed keywords

METHAMPHETAMINE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME DEFICIENCY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SUBSTANTIA NIGRA;

EID: 0033392081     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02087-9     Document Type: Article

References (16)

1. Ali S.F., Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann. N.Y. Acad. Sci. 844:1998;122-130.
2. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32:1998;117-131.
3. Cadet J.L., Sheng P., Ali S.F., Rothman R., Carlson E., Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:1994;380-383.
4. Dawson V.L., Dawson T.M. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10:1996;179-190.
5. Di Monte D.A., Royland J.E., Jakowec M.W., Langston J.W. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. Neurochem. 67:1996;2443-2450.
6. Geller D.A., Billiar T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 17:1998;7-32.
7. Gonzalez-Hernandez T., Rustioni A. Expression of three forms of nitric oxide in peripheral nerve regeneration. J. Neurosci. Res. 55:1999;198-207.
8. Harada S., Imaki T., Chikada N., Naruse M., Demura H. Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection. Brain Res. 821:1999;322-332.
9. Ikeda M., Komachi H., Sato I., Himi T., Yuasa T T., Murota S. Induction of neuronal nitric oxide by methylmercury in the cerebellum. J. Neurosci. Res. 55:1999;352-356.
10. Itzhak Y., Gandia C., Huang P.L., Ali S.F. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284:1998;1040-1047.
11. Murray J.B. Psychophysiological aspects of amphetamine-methamphetamine abuse. J. Psychol. 132:1998;227-237.
12. Seiden L.S., Sabol K.E. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res. Monogr. 163:1996;251-276.
13. Sheng P., Cerruti C., Ali S.F., Cadet J.L. Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells. Ann. N.Y. Acad. Sci. 801:1996;174-186.
14. Sonsalla P.K., Albers D.S., Zeevalk G.D. Role of glutamate in neurodegeneration of dopamine neurons in several animal models of Parkinsonism. Amino Acids. 14:1998;69-74.
15. Stephans S.E., Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse. 17:1994;203-209.
16. Weiss S.W., Albers D.S., Iadarola M.J., Dawson T.M., Dawson V.L., Standaert D.G. NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. J. Neurosci. 18:1998;1725-1734.